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ABSTRACT
PURPOSE: Somatosensory symptoms are common complaints from patients following a Traumatic Brain
Injury (TBI), but are not specific to TBI diagnosis. This study investigated the prevalence of somatosensory
symptoms in TBI patients, evaluated if symptoms severity was associated with TBI severity, and assessed
the relationship of somatosensory complaints to psychological complaints commonly associated with
depression and Post Traumatic Stress Disorder (PTSD). METHODS: Somatic symptoms following traumatic
brain injury (TBI) were assessed using 7 of the 22 items from the Neurobehavioral Symptom Inventory (NSI)
which included headache, nausea, vision problems/blurriness, body numbness/tingling, taste/smell
changes, light sensitivity, and noise sensitivity. RESULTS: Prior to treatment, 90.8% of patients endorsed
clinically-elevated pre-treatment somatosensory symptoms.
The presence of clinically-elevated
somatosensory symptoms decreased after treatment to 77.6%. This demonstrated a high prevalence at
admission of somatosensory complaints in patients with TBI which remained high even after completion of
TBI treatment. Patients with a history of LOC greater than 30 minutes were three times less likely to endorse
clinically-elevated somatosensory complaints when assessed prior to starting treatment as compared to
those with no history of TBI. A similar association was found when evaluated clinically-elevated
somatosensory complaints assessed after treatment. This study also demonstrated patients with clinicallyelevated somatosensory symptoms at admission were more likely to have and clinically-elevated depressive
symptoms post-treatment. Similar significance was found assessing clinically-elevated somatosensory
symptoms as admission and PTSD symptoms. CONCLUSION: Somatosensory symptoms are highly
prevalent in TBI patients, but do not appear to correlate to TBI severity. Additionally, there is a strong
association between somatosensory symptoms and psychological symptoms. The presence of both
somatosensory and psychological symptoms before starting TBI treatment may be considered a strong
indicator that somatosensory complaints will persist following completion of a TBI treatment program.
Patients that endorse a high degree of psychological symptoms may benefit from targeted behavioral health
therapies instead of traditional TBI treatment strategies. Special focus on somatosensory symptoms
assessed by NSI may help guide clinical decision-making when treating TBI patients.
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